All this occurs through the activation of the mitogen-activated protein kinase (MAPK) pathway, which is responsible for ERα transactivation and Cyclin D1 upregulation, resulting in the stimulation of breast cancer cell growth [39,40]. The gene discussed is ESR1; the disease is breast cancer.